Company Encyclopedia
View More
name
Cronos
CRON.US
Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brand names. The company is based in Stayner, Canada.
4.513 T
CRON.USMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
B
PharmaceuticalsIndustry
Industry Ranking25/183
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE3.34%C
    • Profit Margin27.27%A
    • Gross Margin37.32%B
  • Growth ScoreB
    • Revenue YoY19.00%B
    • Net Profit YoY176.09%A
    • Total Assets YoY-0.48%D
    • Net Assets YoY0.07%C
  • Cash ScoreB
    • Cash Flow Margin366.66%C
    • OCF YoY19.00%B
  • Operating ScoreE
    • Turnover0.11E
  • Debt ScoreA
    • Gearing Ratio3.93%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Cronos Group Inc. Stock Rises Wednesday, Outperforms Market

    Cronos Group Inc.'s stock rose 2.03% to $2.51 on Wednesday, outperforming the market. The NASDAQ Composite Index increased by 0.17%, and the Dow Jones Industrial Average rose by 0.86%. Cronos is 20.57% below its 52-week high of $3.16. Trading volume was 1.1 million, below the 50-day average of 1.9 million.

    Dow Jones·
    US
    CRON
    +0.40%
    Dow Jones·
    US
    CRON
    +0.40%

    Cronos Group Inc. Stock Falls Tuesday, Underperforms Market

    Cronos Group Inc. shares fell 1.20% to $2.46 on Tuesday, underperforming the NASDAQ Composite Index, which rose 0.59%, and the Dow Jones Industrial Average, which increased 0.39%. The stock is 22.15% below its 52-week high of $3.16. Trading volume was significantly lower than the 50-day average.

    Dow Jones·
    US
    CRON
    +0.40%
    Dow Jones·
    US
    CRON
    +0.40%

    Cronos subscribes to DoraHacks BUIDL AI, launching the x402 hackathon to reshape the AI ​​finance ecosystem.

    Cronos has subscribed to DoraHacks BUIDL AI, launching the x402 hackathon with a $42,000 prize pool to focus on AI-native payment applications. This initiative aims to leverage Cronos' efficient blockchain technology to recruit global entrepreneurs for building an AI-driven financial hub, enhancing ecosystem reconstruction and innovation.

    CoinLive·
    US
    CRON
    +0.40%
    CoinLive·
    US
    CRON
    +0.40%

    TLRY, CGC, CRON: Cannabis Stocks Jump as U.S. Medicare Considers Coverage

    Cannabis stocks, including Tilray, Canopy Growth, and Cronos Group, surged as U.S. Medicare considers covering CBD treatments for certain patients, potentially boosting the struggling industry. The initiative may focus on seniors receiving cancer or palliative care. This follows a previous rally in September when President Trump supported Medicare coverage for cannabis treatments. Tilray's stock has a Moderate Buy rating, with a price target suggesting significant upside.

    Tip Ranks·
    US
    CGC
    -1.65%
    US
    CRON
    +0.40%
    US
    TLRY
    +1.40%
    Tip Ranks·
    US
    CGC
    -1.65%
    US
    CRON
    +0.40%
    US
    TLRY
    +1.40%

    Cronos Launching Lord Jones Live Resin Fusions in Canada

    07:47 AM EST, 11/25/2025 (MT Newswires) -- Cronos ( CRON ) , a global cannabinoid company, announced Tuesday it is expanding the portfolio for its Lord Jones brand with new innovations designed to enhance its lineup of cannabis products in the Canadian market. With that, the company is launching new Live Resin Fusions pre-rolls. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

    fidelity·
    US
    CRON
    +0.40%
    fidelity·
    US
    CRON
    +0.40%
    © 2025 Longbridge｜Disclaimer